{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:57:18Z","timestamp":1790650638234,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Muscle-related symptoms are among the most disabling manifestations of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS), yet their position within the broader symptom architecture of the disease remains unclear. We hypothesized that muscle symptoms may represent a candidate integrative symptom within a broader shared symptom-dysregulation structure and their symptom associations differ according to sex and menopausal status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional data from 736 individuals with physician-diagnosed ME\/CFS enrolled in the APAV-ME\/CFS registry were analysed. Muscle problems served as the primary outcome variable. Associations with 14 symptom domains were examined using multivariable logistic regression. Pearson and tetrachoric correlations, exploratory factor analysis, and structural equation modeling (SEM) were used to identify latent symptom structures. Exploratory analyses were stratified by sex, menopausal status, and disease duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the full multivariable model (non-robust estimates), breathing problems (OR 2.49 [95% Conf. Interval: 1.42\u20134.38],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), flu-like symptoms (OR 1.97 [1.14\u20133.42],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015), and temperature-regulation disorders (OR 1.97 [1.10\u20133.51],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021) independently predicted muscle problems. A reduced physiological model (not-robust estimates) additionally identified cardiovascular symptoms (OR 1.87 [1.09\u20133.24],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.024) as a significant predictor. Tetrachoric correlations demonstrated substantial latent associations between muscle problems and breathing difficulties (\u03c1\u2009=\u20090.52), cardiovascular symptoms (\u03c1\u2009=\u20090.49), temperature-regulation disorders (\u03c1\u2009=\u20090.49), visual disturbances (\u03c1\u2009=\u20090.39), and flu-like symptoms (\u03c1\u2009=\u20090.39). Factor analysis and SEM supported a single latent physiological dysregulation factor with good model fit (RMSEA\u2009=\u20090.046, CFI\u2009=\u20090.971, TLI\u2009=\u20090.952, SRMR\u2009=\u20090.026). The sex-stratified analyses revealed differences in the pattern of statistically significant symptom associations across the subgroups. However, the overall test of the symptom-by-sex interaction terms did not provide evidence for a statistically established difference in the symptom associations by sex. Thus, the subgroup-specific patterns should primarily be interpreted as descriptive and exploratory. At the individual symptom level, the association between breathing-related symptoms and muscle problems showed a statistically significant interaction with sex, suggesting that this association may differ between women and men. However, this finding should be interpreted cautiously given the non-significant overall interaction test and the wide confidence interval of the interaction estimate.\n                    <\/jats:p>\n                    <jats:p>\n                      In women, all five physiological symptoms independently predicted muscle problems, whereas in men only breathing problems and temperature-regulation disorders remained significant. Women classified as premenopausal and postmenopausal based on an age-defined proxy showed different patterns of symptom associations with muscle problems in subgroup-specific analyses. Women in the premenopausal age-proxy group showed significant associations with cardiovascular symptoms, visual disturbances, and temperature-regulation disorders, whereas women classified as postmenopausal showed significant associations with breathing difficulties and flu-like symptoms. However, the overall menopausal-by-symptom interaction was not statistically significant (Wald \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      (5)=5.96,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.310).\n                    <\/jats:p>\n                    <jats:p>The specified latent physiological factor showed statistical comparability across the cross-sectional disease-duration groups. Gastrointestinal complaints loaded substantially on the latent factor despite lacking an independent association with muscle problems in multivariable regression. Urogenital symptoms also showed a smaller but significant association with the latent factor and substantial item-specific variance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Muscle symptoms may represent a candidate integrative symptom within a latent physiological symptom-dysregulation factor encompassing respiratory, cardiovascular, thermoregulatory, visual, and flu-like symptoms in this ME\/CFS sample. Secondary analyses suggested that gastrointestinal complaints were also part of the broader physiological symptom pattern, although they were not independently associated with muscle problems. The specified latent physiological factor showed no overall statistical evidence of measurement differences across the cross-sectional disease-duration groups. However, subgroup-specific symptom patterns differed descriptively by sex and age-defined menopausal-status proxy group. Women classified as premenopausal were characterized primarily by cardiovascular, visual, and thermoregulatory symptom associations, whereas women classified as postmenopausal and men showed greater prominence of breathing-related symptoms. Flu-like symptoms were independently associated with muscle problems in the postmenopausal subgroup but not in the premenopausal subgroup. Because the corresponding interaction term was not statistically significant, this subgroup contrast should be interpreted as an exploratory difference in association rather than as evidence of a menopause-specific effect.<\/jats:p>\n                    <jats:p>More broadly, the findings are compatible with the hypothesis that the latent symptom-dysregulation factor may reflect a chronic PEM-associated multisystem response. Whether this symptom-dysregulation factor corresponds to interacting autonomic, vascular, immunological, and metabolic processes remains to be determined by longitudinal and biomarker-based studies. ME\/CFS phenotyping may improve patient stratification and facilitate the development of mechanism-based therapeutic approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-09018-9","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:27:00Z","timestamp":1790591220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Muscle symptoms and a latent physiological symptom-dysregulation factor in ME\/CFS: exploratory analyses by sex and age-defined menopausal-status proxy group"],"prefix":"10.1186","volume":"24","author":[{"given":"Lotte","family":"Habermann-Horstmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas M.","family":"Horstmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"1","key":"9018_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-021-02833-2","volume":"19","author":"KJ Wirth","year":"2021","unstructured":"Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Transl Med. 2021;19(1):162. https:\/\/doi.org\/10.1186\/s12967-021-02833-2.","journal-title":"J Transl Med"},{"key":"9018_CR2","doi-asserted-by":"publisher","unstructured":"Scheibenbogen C, Wirth KJ. Key pathophysiological role of skeletal muscle disturbance in post COVID and myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): accumulated evidence. J Cachexia, Sarcopenia Muscle. 2025;16(1):e13669. https:\/\/doi.org\/10.1002\/jcsm.13669.","DOI":"10.1002\/jcsm.13669"},{"issue":"1","key":"9018_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/21641846.2025.2556941","volume":"14","author":"JL Nuzzo","year":"2026","unstructured":"Nuzzo JL, Taylor JL, Latella C. Muscle strength, muscle endurance, voluntary activation, and perception of effort in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): an overview. Fatigue: Biomed, Health Behav. 2026;14(1):42\u201360. https:\/\/doi.org\/10.1080\/21641846.2025.2556941.","journal-title":"Fatigue: Biomed, Health Behav"},{"issue":"6","key":"9018_CR4","doi-asserted-by":"publisher","first-page":"102527","DOI":"10.1016\/j.autrev.2020.102527","volume":"19","author":"K Wirth","year":"2020","unstructured":"Wirth K, Scheibenbogen C. A unifying hypothesis of the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): recognitions from the finding of autoantibodies against \u00df2-adrenergic receptors. Autoimmun Rev. 2020;19(6):102527. https:\/\/doi.org\/10.1016\/j.autrev.2020.102527.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"9018_CR5","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/pm\/pnab308","volume":"23","author":"EE Barhorst","year":"2022","unstructured":"Barhorst EE, Boruch AE, Cook DB, Lindheimer JB. Pain-related post-exertional malaise in myalgic encephalomyelitis \/ chronic fatigue syndrome (ME\/CFS) and fibromyalgia: a systematic review and three-level meta-analysis. Pain Med. 2022;23(6):1144\u201357. https:\/\/doi.org\/10.1093\/pm\/pnab308.","journal-title":"Pain Med"},{"issue":"4","key":"9018_CR6","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00056.2024","volume":"40","author":"AM Syed","year":"2025","unstructured":"Syed AM, Karius AK, Ma J, Wang PY, Hwang PM. Mitochondrial dysfunction in myalgic encephalomyelitis\/chronic fatigue syndrome. Physiol (Bethesda). 2025;40(4):0. https:\/\/doi.org\/10.1152\/physiol.00056.2024.","journal-title":"Physiol (Bethesda)"},{"issue":"3","key":"9018_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/diagnostics9030080","volume":"9","author":"D Missailidis","year":"2019","unstructured":"Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis\/chronic fatigue syndrome. Diagn (Basel). 2019;9(3):80. https:\/\/doi.org\/10.3390\/diagnostics9030080.","journal-title":"Diagn (Basel)"},{"key":"9018_CR8","doi-asserted-by":"publisher","first-page":"888232","DOI":"10.3389\/fncel.2022.888232","volume":"16","author":"H Renz-Polster","year":"2022","unstructured":"Renz-Polster H, Tremblay ME, Bienzle D, Fischer JE. The pathobiology of myalgic encephalomyelitis\/chronic fatigue syndrome: the case for neuroglial failure. Front Cell Neurosci. 2022;16:888232. https:\/\/doi.org\/10.3389\/fncel.2022.888232.","journal-title":"Front Cell Neurosci"},{"key":"9018_CR9","doi-asserted-by":"publisher","first-page":"1386607","DOI":"10.3389\/fimmu.2024.1386607","volume":"15","author":"HE Arron","year":"2024","unstructured":"Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic encephalomyelitis\/chronic fatigue syndrome: the biology of a neglected disease. Front. Immunol. 2024;15:1386607. https:\/\/doi.org\/10.3389\/fimmu.2024.1386607.","journal-title":"Front. Immunol"},{"key":"9018_CR10","doi-asserted-by":"publisher","first-page":"100995","DOI":"10.1016\/j.yfrne.2022.100995","volume":"66","author":"N Thomas","year":"2022","unstructured":"Thomas N, Gurvich C, Huang K, Gooley PR, Armstrong CW. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front Neuroendocrinol. 2022;66:100995. https:\/\/doi.org\/10.1016\/j.yfrne.2022.100995.","journal-title":"Front Neuroendocrinol"},{"key":"9018_CR11","doi-asserted-by":"publisher","unstructured":"Habermann-Horstmeier L, Horstmeier LM. Symptome der myalgischen enzephalomyelitis\/des chronischen fatigue-syndroms (ME\/CFS) im Krankheitsverlauf. Pr\u00e4v Gesundheitsf. 2025. https:\/\/doi.org\/10.1007\/s11553-025-01280-x.","DOI":"10.1007\/s11553-025-01280-x"},{"key":"9018_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/s12967-026-08159-1","volume":"24","author":"L Habermann-Horstmeier","year":"2026","unstructured":"Habermann-Horstmeier L, Horstmeier LM. Symptom clusters in ME\/CFS reflect distinct neuroimmune and autonomic pathophysiological mechanisms: a translational model. J Transl Med. 2026;24:606. https:\/\/doi.org\/10.1186\/s12967-026-08159-1.","journal-title":"J Transl Med"},{"key":"9018_CR13","unstructured":"Habermann-Horstmeier L, Horstmeier LM. Sex-specific differences in neurocognitive-sensory and autonomic ME\/CFS symptomatology: evidence from structural equation modeling with implications for a pathophysiological model. Under Rev Bull Natl Res Cent."},{"key":"9018_CR14","doi-asserted-by":"publisher","unstructured":"Habermann-Horstmeier L, Horstmeier LM. Sex- and menopause-related differences in immune and gastrointestinal symptom architecture in ME\/CFS:evidence from factor analysis and structural equation modeling. J Transl Med. 2026;24(1):970 https:\/\/doi.org\/10.1186\/s12967-026-08699-6","DOI":"10.1186\/s12967-026-08699-6"},{"issue":"1","key":"9018_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","volume":"11","author":"BM Carruthers","year":"2003","unstructured":"Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11(1):7\u2013115. https:\/\/doi.org\/10.1300\/J092v11n01_02. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK274235\/pdf\/Bookshelf_NBK274235.pdf. 5 September 2026.","journal-title":"J Chronic Fatigue Syndr"},{"issue":"4","key":"9018_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011;270(4):327\u201338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x.","journal-title":"J Intern Med"},{"issue":"12","key":"9018_CR17","doi-asserted-by":"publisher","first-page":"102514","DOI":"10.1016\/j.xcrm.2025.102514","volume":"6","author":"B Heng","year":"2025","unstructured":"Heng B, Gunasegaran B, Krishnamurthy S, Bustamante S, Pires AS, Chow S, et al. Mapping the complexity of ME\/CFS: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction. Cell Rep Med. 2025;6(12):102514. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102514 (accessed on 5 September 2026).","journal-title":"Cell Rep Med"},{"key":"9018_CR18","doi-asserted-by":"publisher","unstructured":"Fluge \u00d8, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy\/chronic fatigue syndrome. JCI Insight. 2016;1(21):e89376. https:\/\/doi.org\/10.1172\/jci.insight.89376.","DOI":"10.1172\/jci.insight.89376"},{"issue":"1","key":"9018_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/metabo10010034","volume":"10","author":"A Germain","year":"2020","unstructured":"Germain A, Barupal DK, Levine SM, Hanson MR. Comprehensive circulatory metabolomics in ME\/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites. 2020;10(1):34. https:\/\/doi.org\/10.3390\/metabo10010034.","journal-title":"Metabolites"},{"issue":"14","key":"9018_CR20","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.3390\/ijms23147906","volume":"23","author":"X Che","year":"2022","unstructured":"Che X, Brydges CR, Yu Y, Price A, Joshi S, Roy A, et al. Metabolomic evidence for peroxisomal dysfunction in myalgic Encephalomyelitis\/Chronic fatigue syndrome. Int J Mol Sci. 2022;23(14):7906. https:\/\/doi.org\/10.3390\/ijms23147906.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9018_CR21","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1038\/s41598-021-89834-9","volume":"11","author":"J Blauensteiner","year":"2021","unstructured":"Blauensteiner J, Bertinat R, Le\u00f3n LE, Riederer M, Sep\u00falveda N, Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME\/CFS patients. Sci Rep. 2021;11(1):10604. https:\/\/doi.org\/10.1038\/s41598-021-89834-9.","journal-title":"Sci Rep"},{"key":"9018_CR22","doi-asserted-by":"publisher","first-page":"106953","DOI":"10.1016\/j.vph.2022.106953","volume":"143","author":"R Bertinat","year":"2022","unstructured":"Bertinat R, Villalobos-Labra R, Hofmann L, Blauensteiner J, Sep\u00falveda N, Westermeier F. Decreased NO production in endothelial cells exposed to plasma from ME\/CFS patients. Vascul Pharmacol. 2022;143:106953. https:\/\/doi.org\/10.1016\/j.vph.2022.106953.","journal-title":"Vascul Pharmacol"},{"key":"9018_CR23","doi-asserted-by":"publisher","unstructured":"Sandvik MK, S\u00f8rland K, Leirgul E, Rekeland IG, Stavland CS, et al. Endothelial dysfunction in ME\/CFS patients. PLoS One. 2023;18(2):e0280942. https:\/\/doi.org\/10.1371\/journal.pone.0280942.","DOI":"10.1371\/journal.pone.0280942"},{"key":"9018_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cnp.2020.01.003","volume":"5","author":"VC Clmc","year":"2020","unstructured":"Clmc VC, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME\/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using doppler echography. Clin Neurophysiol Pract. 2020;5:50\u201358. https:\/\/doi.org\/10.1016\/j.cnp.2020.01.003.","journal-title":"Clin Neurophysiol Pract"},{"issue":"2","key":"9018_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.chest.2021.01.082","volume":"160","author":"P Joseph","year":"2021","unstructured":"Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis\/chronic fatigue syndrome. Chest. 2021;160(2):642\u201351. https:\/\/doi.org\/10.1016\/j.chest.2021.01.082.","journal-title":"Chest"},{"key":"9018_CR26","doi-asserted-by":"publisher","first-page":"204390","DOI":"10.1155\/2014\/204390","volume":"2014","author":"KL Moreau","year":"2014","unstructured":"Moreau KL, Hildreth KL. Vascular aging across the menopause transition in healthy women. Adv Vasc Med. 2014;2014:204390. https:\/\/doi.org\/10.1155\/2014\/204390.","journal-title":"Adv Vasc Med"},{"key":"9018_CR27","doi-asserted-by":"publisher","unstructured":"SenthilKumar G, Katunaric B, Bordas-Murphy H, Sarvaideo J, Freed JK. Estrogen and the vascular endothelium: the unanswered questions. Endocrinology. 2023;164(6):bqad079. https:\/\/doi.org\/10.1210\/endocr\/bqad079.","DOI":"10.1210\/endocr\/bqad079"},{"key":"9018_CR28","doi-asserted-by":"publisher","first-page":"103295","DOI":"10.1016\/j.autneu.2025.103295","volume":"260","author":"J Lee","year":"2025","unstructured":"Lee J, Keller-Ross ML. Menopause and its effects on autonomic regulation of blood pressure: insights and perspectives. Auton Neurosci. 2025;260:103295. https:\/\/doi.org\/10.1016\/j.autneu.2025.103295.","journal-title":"Auton Neurosci"},{"key":"9018_CR29","unstructured":"Jauert N, Schilling-Ziese K, Meyer A, Heigl M, Scheibenbogen C, Doehner W, et al. Skeletal Muscle Metabolism in Women with ME\/CFS. Poster presented at: International ME\/CFS Conference. Berlin, Germany: 2026 May. https:\/\/events.mecfs-research.org\/de\/events\/conference_2026\/posters."},{"key":"9018_CR30","unstructured":"Pipper-Krampl C, Jeremic D, Wagner B, Hausl M, Raml R, Eberl A, et al. Sex\u2011specific alterations in arginine\u2011NO and polyamine metabolism in ME\/CFS. Poster presented at: International ME\/CFS Conference. Berlin: 2026. https:\/\/events.mecfs-research.org\/de\/events\/conference_2026\/posters."},{"key":"9018_CR31","unstructured":"Schmitz J, Sotzny F, Kedor C, et al. Distinct autoantibody profiles targeting G\u2011protein\u2011coupled receptors in subgroups of a large post\u2011infectious ME\/CFS cohort. Poster presented at: International ME\/CFS Conference. Berlin, Germany: 2026 May. https:\/\/events.mecfs-research.org\/de\/events\/conference_2026\/posters."},{"key":"9018_CR32","unstructured":"Dros M, Mocking TR, Vroegindeweij A, et al. Dysregulated arachidonic acid metabolism is a shared feature among post\u2011acute infectious syndromes: preliminary results from the QVS study. Poster presented at: International ME\/CFS Conference. Berlin, Germany: 2026 May. https:\/\/events.mecfs-research.org\/de\/events\/conference_2026\/posters."},{"issue":"10","key":"9018_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338. https:\/\/doi.org\/10.1038\/nri.2016.90.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"9018_CR34","doi-asserted-by":"publisher","first-page":"103855","DOI":"10.1016\/j.autrev.2025.103855","volume":"24","author":"O Cabral-Marques","year":"2025","unstructured":"Cabral-Marques O, Schimke LF, Moll G, et al. Advancing research on regulatory autoantibodies targeting GPCRs: insights from the 5th international symposium. Autoimmun Rev. 2025;24(9):103855. https:\/\/doi.org\/10.1016\/j.autrev.2025.103855.","journal-title":"Autoimmun Rev"},{"issue":"14","key":"9018_CR35","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.96.14.7710","volume":"96","author":"LR Watkins","year":"1999","unstructured":"Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci U S A. 1999;96(14):7710\u201313. https:\/\/doi.org\/10.1073\/pnas.96.14.7710.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9018_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/13697137.2018.1430131","volume":"21","author":"RC Thurston","year":"2018","unstructured":"Thurston RC. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health. Climacteric. 2018;21(2):96\u2013100. https:\/\/doi.org\/10.1080\/13697137.2018.1430131.","journal-title":"Climacteric"},{"issue":"2","key":"9018_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cellimm.2015.02.002","volume":"294","author":"MR Gubbels Bupp","year":"2015","unstructured":"Gubbels Bupp MR. Sex, the aging immune system, and chronic disease. Cell Immunol. 2015;294(2):102\u201310. https:\/\/doi.org\/10.1016\/j.cellimm.2015.02.002.","journal-title":"Cell Immunol"},{"issue":"11","key":"9018_CR38","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"J Hoffmann","year":"2023","unstructured":"Hoffmann J, Liu J, Seddu K, et al. Sex hormone signaling and regulation of immune function. Immunity. 2023;56(11):2472\u201391. https:\/\/doi.org\/10.1016\/j.immuni.2023.10.008.","journal-title":"Immunity"},{"issue":"11","key":"9018_CR39","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1016\/j.cell.2026.04.042","volume":"189","author":"K de S\u00e1","year":"2026","unstructured":"de S\u00e1 K, Silva J, Bayarri-Olmos R, et al. A causal link between autoantibodies and neurological symptoms in long COVID. Cell. 2026;189(11):3214\u201335.e37. https:\/\/doi.org\/10.1016\/j.cell.2026.04.042.","journal-title":"Cell"},{"key":"9018_CR40","doi-asserted-by":"publisher","unstructured":"Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12(5):e8094. https:\/\/doi.org\/10.7759\/cureus.8094.","DOI":"10.7759\/cureus.8094"},{"key":"9018_CR41","unstructured":"Johns Hopkins Medicine. What is post-exertional malaise? https:\/\/www.hopkinsmedicine.org\/-\/media\/johns-hopkins-childrens-center\/documents\/specialties\/adolescent-medicine\/cfs-pem-info.pdf. 20 June 2026."},{"key":"9018_CR42","doi-asserted-by":"publisher","unstructured":"IOM - Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Board on the health of select populations. Beyond Myalgic Encephalomyelitis\/ Chronic Fatigue Syndrome: Redefining an Illness. Washington (DC): Institute of Medicine: National Academies Press (US); 2015. https:\/\/doi.org\/10.17226\/19012.","DOI":"10.17226\/19012"},{"key":"9018_CR43","doi-asserted-by":"publisher","unstructured":"Flanagan KL, Klein SL. Knowledge gaps and research priorities to understand sex differences in immunity. PLoS Biol. 2026;24(2):e3003578. https:\/\/doi.org\/10.1371\/journal.pbio.3003578.","DOI":"10.1371\/journal.pbio.3003578"},{"issue":"4","key":"9018_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update. 2005;11(4):411\u201323. https:\/\/doi.org\/10.1093\/humupd\/dmi008.","journal-title":"Hum Reprod Update"},{"key":"9018_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","volume":"10","author":"C Libert","year":"2010","unstructured":"Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10:594\u2013604. https:\/\/doi.org\/10.1038\/nri2815.","journal-title":"Nat Rev Immunol"},{"key":"9018_CR46","doi-asserted-by":"publisher","unstructured":"Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19):eaap8855. https:\/\/doi.org\/10.1126\/sciimmunol.aap8855.","DOI":"10.1126\/sciimmunol.aap8855"},{"issue":"3","key":"9018_CR47","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","volume":"187","author":"D Dou","year":"2024","unstructured":"Dou D, Zhao Y, Belk J, et al. Xist ribonucleoproteins promote female sex-biased autoimmunity. Cell. 2024;187(3):733\u201349.e16. https:\/\/doi.org\/10.1016\/j.cell.2023.12.037.","journal-title":"Cell"},{"key":"9018_CR48","doi-asserted-by":"publisher","first-page":"1142723","DOI":"10.3389\/fimmu.2023.1142723","volume":"14","author":"RG Lahita","year":"2023","unstructured":"Lahita RG. Sex and gender influence on immunity and autoimmunity. Front Immunol. 2023;14:1142723. https:\/\/doi.org\/10.3389\/fimmu.2023.1142723.","journal-title":"Front Immunol"},{"key":"9018_CR49","doi-asserted-by":"publisher","unstructured":"Brostr\u00f6m A, Alimoradi Z, Lind J, Ulander M, Lundin F, Pakpour A. Worldwide estimation of restless legs syndrome: a systematic review and meta-analysis of prevalence in the general adult population. J Sleep Res. 2023;32(3):e13783. https:\/\/doi.org\/10.1111\/jsr.13783.","DOI":"10.1111\/jsr.13783"},{"issue":"1","key":"9018_CR50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/ijerph17010368","volume":"17","author":"MV Seeman","year":"2020","unstructured":"Seeman MV. Why are women prone to restless legs syndrome? Int J Environ Res Public Health. 2020;17(1):368. https:\/\/doi.org\/10.3390\/ijerph17010368.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"9018_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.smrv.2011.04.001","volume":"16","author":"KE Innes","year":"2012","unstructured":"Innes KE, Selfe TK, Agarwal P. Restless legs syndrome and conditions associated with metabolic dysregulation, sympathoadrenal dysfunction, and cardiovascular disease risk: a systematic review. Sleep Med Rev. 2012;16(4):309\u201339. https:\/\/doi.org\/10.1016\/j.smrv.2011.04.001.","journal-title":"Sleep Med Rev"},{"issue":"7","key":"9018_CR52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0022-2275(20)37695-1","volume":"34","author":"M Lafontan","year":"1993","unstructured":"Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 1993;34(7):1057\u201391. https:\/\/doi.org\/10.1016\/S0022-2275(20)37695-1. https:\/\/pubmed.ncbi.nlm.nih.gov\/8371057\/.","journal-title":"J Lipid Res"},{"issue":"1","key":"9018_CR53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","volume":"18","author":"TR Gossard","year":"2021","unstructured":"Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics. 2021;18(1):140\u201355. https:\/\/doi.org\/10.1007\/s13311-021-01019-4.","journal-title":"Neurotherapeutics"},{"issue":"16","key":"9018_CR54","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.3390\/jcm10163675","volume":"10","author":"H Freitag","year":"2021","unstructured":"Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A, et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis\/chronic fatigue syndrome. J Clin Med. 2021;10(16):3675. https:\/\/doi.org\/10.3390\/jcm10163675.","journal-title":"J Clin Med"},{"key":"9018_CR55","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.bbih.2020.100107","volume":"7","author":"A Bynke","year":"2020","unstructured":"Bynke A, Julin P, Gottfries CG, Heidecke H, Scheibenbogen C, Bergquist J. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in myalgic encephalomyelitis (ME) patients - a validation study in plasma and cerebrospinal fluid from two Swedish cohorts. Brain Behav Immun Health. 2020;7:100107. https:\/\/doi.org\/10.1016\/j.bbih.2020.100107.","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"9018_CR56","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","volume":"9","author":"O Cabral-Marques","year":"2018","unstructured":"Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, G\u00fcnther J, et al. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat Commun. 2018;9(1):5224. https:\/\/doi.org\/10.1038\/s41467-018-07598-9.","journal-title":"Nat Commun"},{"key":"9018_CR57","unstructured":"NIH (National Institutes of Health). Report of the ME\/CFS research roadmap working group of council. 2024, May, 15. https:\/\/www.ninds.nih.gov\/sites\/default\/files\/2024-05\/Report%20of%20the%20MECFS%20Research%20Roadmap%20Working%20Group%20of%20Council_508C.pdf. 20 June 2026."}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-09018-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-09018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-09018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:03:28Z","timestamp":1790647408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-09018-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9018"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-09018-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in 2022 in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Furtwangen University, Germany (application number: 22-057).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were fully informed about the objectives and procedure before the study began and gave written consent to participate. See the information sheet and consent form in the \u201cSupplementary files\u201d section.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The translation from German was supported by\n                      \n                      (free version). Furthermore, we would like to thank the AI tool ChatGPT (OpenAI) for language editing and wording optimization in individual sections under human guidance. All ideas, data and interpretations originate from the authors.","order":4,"name":"Ethics","label":"Additional notes","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author declares on behalf of all authors that there is no conflict of interest.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1216"}}